<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        106-124-17
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2017
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        GLUMINE 3 mg Tablet
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        GLIMEPIRIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        3
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        21.25
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="DAR ALDAWA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            DAR ALDAWA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 530]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Salehiya Trading Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            DAR ALDAWA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A10BB12
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Glumine&reg; is a medicine taken by mouth to help lower blood sugar. It belongs to a group of medicines called sulfonylureas.</p><p>Glumine&reg; works by increasing the amount of insulin released from your pancreas. The insulin then lowers your blood sugar levels.</p><p>What Glumine&reg; is used for:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Glumine&reg; is used to treat a certain form of diabetes (type 2 diabetes mellitus) when diet, physical exercise and weight reduction alone have not been able to control your blood sugar levels.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Glumine<sup>&reg;</sup></strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You are allergic to: glimepiride or other sulfonylureas (medicines used to lower your blood sugar such as glibenclamide) or sulfonamides (medicines for bacterial infections such as sulfamethoxazole) or any of the other ingredients of this medicine</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have insulin dependent diabetes (type 1 diabetes mellitus)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have diabetic ketoacidosis (a complication of diabetes when your acid level is raised in your body and you may have some of the following signs: fatigue, feeling sick (nausea), frequent urination and muscular stiffness)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You are in a diabetic coma</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have severe kidney disease</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have a severe liver disease</p><p>Do not take this medicine if any of the above apply to you.</p><p>If you are not sure, talk to your doctor or pharmacist before taking <strong>Glumine<sup>&reg;</sup></strong>.</p><p>&nbsp;</p><p><strong>Take special care with Glumine<sup>&reg;</sup></strong></p><p><strong>Talk to your doctor or pharmacist before taking your medicine if:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You are recovering from an injury, operation, infections with fever, or from other forms of stress, inform your doctor as temporary change of treatment may be necessary</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have a severe liver or kidney disorder</p><p>If you are not sure if any of these apply to you, talk to your doctor or pharmacist before taking <strong>Glumine<sup>&reg;</sup></strong>.</p><p>Lowering of the haemoglobin level and breakdown of red blood cells (haemolytic anemia) can occur in patients missing the enzyme glucose-6-phosphate dehydrogenase.</p><p>The information available on the use of <strong>Glumine<sup>&reg;</sup></strong> in people under 18 years of age is limited. Therefore, its use in these patients is not recommended.</p><p><strong>Important </strong><strong>information</strong><strong> about hypoglycaemia (low blood sugar)</strong></p><p>When you take <strong>Glumine<sup>&reg;</sup></strong>, you may get hypoglycaemia (low blood sugar). Please see below for additional information about hypoglycaemia, its signs and treatment.</p><p><strong>Following factors could increase the risk of you getting hypoglycaemia:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Undernourishment, irregular meal time, missed or delayed meal or period of fasting</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes to your diet</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Taking more <strong>Glumine<sup>&reg;</sup></strong> than needed</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Having kidneys that do not work properly</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Having severe liver disease</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you suffer from particular hormone-induced disorders (disorders of the thyroid glands, of the pituitary gland or adrenal cortex)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Drinking alcohol (especially when you skip a meal)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Taking certain other medicines</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you increase the amount of exercise you do and you don&#39;t eat enough food or eat food containing less carbohydrate than usual.</p><p><strong>Signs of hypoglycaemia include:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hunger pangs, headache, nausea, vomiting, sluggishness, sleepiness, problems sleeping, restlessness, aggression, problems with concentration, reduced alertness and reaction time, depression, confusion, problems with your speech and sight, slurred speech, shakiness, partial paralysis, dizziness, helplessness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The following signs may also occur: sweating, clammy skin, anxiety, fast or increased heart beat, high blood pressure, awareness of your heart beat, sudden strong pain in the breast that may radiate into neighbouring areas (angina pectoris and cardiac arrhythmias)</p><p>If blood sugar levels continue to drop you may suffer from considerable confusion (delirium), develop fits, lose self control, breathing may be shallow and your heart beat slowed down, you may fall into unconsciousness. The clinical picture of a severe reduced blood sugar level may resemble that of a stroke.</p><p><strong>Treating hypoglycaemia:</strong></p><p>In most cases the signs of reduced blood sugar vanish very quickly when you consume some form of sugar, e.g. sugar cubes, sweet juice, sweetened tea.</p><p>You should therefore always take some form of sugar with you (e.g. sugar cubes). Remember that artificial sweeteners are not effective. Please contact your doctor or go to the hospital if taking sugar does not help or if the symptoms recur.</p><p><strong>Laboratory tests</strong></p><p>The level of sugar in your blood or urine should be checked regularly. Your doctor may also take blood tests to monitor your blood cell levels and liver function.</p><p><strong>Children and adolescents</strong></p><p><strong>Glumine<sup>&reg;</sup></strong> is not recommended for use in children under 18 years of age.</p><p>&nbsp;</p><p><strong>Taking other medicines, herbal or dietary supplements</strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.</p><p>Your doctor may wish to change your dose of <strong>Glumine<sup>&reg;</sup></strong> if you are taking other medicines, which may weaken or strengthen the effect of <strong>Glumine<sup>&reg;</sup></strong> on the level of sugar in your blood.</p><p>The following medicines can increase the blood sugar lowering effect of <strong>Glumine<sup>&reg;</sup></strong>. This can lead to a risk of hypoglycaemia (low blood sugar):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other medicines to treat diabetes mellitus (such as insulin or metformin)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat pain and inflammation (phenylbutazone, azopropazone, oxyphenbutazone, aspirin-like medicines)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat urinary infections (such as some long acting sulfonamides)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat bacterial and fungal infections (tetracyclines, chloramphenicol, fluconazole, miconazole, quinolones, clarithromycin)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to inhibit blood clotting (coumarin derivatives such as warfarin)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines supporting muscle build up (anabolics)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines used for male sex hormone replacement therapy</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat depression (fluoxetine, MAO inhibitors)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines lowering high cholesterol level (fibrates)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines lowering high blood pressure (ACE inhibitors)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines called anti-arrhythmic agents used to control abnormal heart beat (disopyramide)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat gout (allopurinol, probenecid, sulfinpyrazone)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat cancer (cyclophosphamide, ifosfamide, trofosfamide)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines used to reduce weight (fenfluramine)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to increase circulation when given in a high dose intravenous infusion (pentoxifylline)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat nasal allergies such as hay fever (tritoqualine)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines called sympatholytics to treat high blood pressure, heart failure, or prostate symptoms</p><p>The following medicines may decrease the blood sugar lowering effect of <strong>Glumine<sup>&reg;</sup></strong>. This can lead to a risk of hyperglycaemia (high blood sugar level):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines containing female sex hormones (oestrogens, progestogens)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat high blood pressure called thiazide diuretics (water tablets)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines used to stimulate the thyroid gland (such as levothyroxine)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat allergies and inflammation (glucocorticoids)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat severe mental disorders (chlorpromazine and other phenothiazine derivatives)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines used to raise heart beat, to treat asthma or nasal congestion, coughs and colds, used to reduce weight, or used in life-threatening emergencies (adrenaline and sympathomimetics)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat high cholesterol level (nicotinic acid)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat constipation when they are used long term (laxatives)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat fits (phenytoin)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat nervousness and sleep problems (barbiturates)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat increased pressure in the eye (azetazolamide)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat high blood pressure or lowering blood sugar (diazoxide)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat infections, tuberculosis (rifampicine)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat severe low blood sugar levels (glucagon)</p><p>The following medicines can increase or decrease the blood sugar lowering effect of <strong>Glumine<sup>&reg;</sup>:</strong><sup> </sup></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat stomach ulcers (called H2 antagonists)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat high blood pressure or heart failure such as beta-blockers, clonidine, guanethidine and reserpine. These can also hide the signs of hypoglycaemia, so special care is needed when taking these medicines</p><p><strong>Glumine<sup>&reg;</sup></strong> may either increase or weaken the effects of the following medicines:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines inhibiting blood clotting (coumarin derivatives such as warfarin).</p><p>&nbsp;</p><p><strong>Taking Glumine<sup>&reg;</sup> with food and drink</strong></p><p>Alcohol intake may increase or decrease the blood sugar lowering action of <strong>Glumine<sup>&reg;</sup></strong> in an unpredictable way.</p><p>&nbsp;</p><p><strong>Pregnancy and breastfeeding</strong></p><p><strong>Pregnancy</strong></p><p><strong>Glumine<sup>&reg;</sup></strong> should not be taken during pregnancy. Tell your doctor if you are, you think you might be or are planning to become pregnant.</p><p><strong>Breast-feeding</strong></p><p><strong>Glumine<sup>&reg;</sup></strong> may pass into breast milk. <strong>Glumine<sup>&reg;</sup></strong> should not be taken during breast feeding.</p><p>Ask your doctor or pharmacist for advice before taking any medicine.</p><p><strong>&nbsp;</strong></p><p><strong>Driving and using machines</strong></p><p>Your ability to concentrate or react may be reduced if your blood sugar is lowered (hypoglycaemia), or raised (hyperglycaemia) or if you develop visual problems as a result of such conditions. Bear in mind that you could endanger yourself or others (e.g. when driving a car or using machines). Please ask your doctor whether you can drive a car if you:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; have frequent episodes of hypoglycaemia,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; have fewer or no warning signals of hypoglycaemia.</p><p><u>&nbsp;</u></p><p><strong>Important information about some of the ingredients of </strong><strong>Glumine<sup>&reg; </sup></strong></p><p><strong>Glumine<sup>&reg;</sup></strong> tablets contain lactose, if you have been told by your doctor that you have intolerance to some sugars, contact your doctor before taking this medicinal product.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.</p><p><strong>Taking </strong><strong>this</strong><strong> medicine</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Take this medicine by mouth, just before or with the first main meal of the day (usually breakfast). If you do not have breakfast you should take the medicine on schedule as prescribed by your doctor. It is important not to leave out any meal when you are on <strong>Glumine<sup>&reg;</sup></strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swallow the tablets with at least half glass of water. Do not crush or chew the tablets.</p><p><strong>How </strong><strong>much</strong><strong> to take</strong></p><p>The dose of <strong>Glumine<sup>&reg;</sup></strong> depends on your needs, condition and results of blood and urine sugar tests and is determined by your doctor. Do not take more tablets than your doctor has prescribed.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The usual starting dose is one <strong>Glumine<sup>&reg;</sup></strong> 1 mg tablet once a day</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If necessary, your doctor may increase the dose after each 1 - 2 weeks of treatment</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The maximum recommended dose is 6 mg <strong>Glumine<sup>&reg;</sup></strong> per day</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A combination therapy of glimepiride plus metformin or of glimepiride plus insulin may be started. In such a case your doctor will determine the proper doses of glimepiride, metformin or insulin individually for you</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Your dose of <strong>Glumine<sup>&reg;</sup></strong> may need to be adjusted if you change weight, change your lifestyle, or if you are under a lot of stress. Please speak to your doctor if any of these situations apply to you.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you feel the effect of your medicine is too weak or too strong do not change the dose yourself, but ask your doctor.</p><p>&nbsp;</p><p><strong>If you </strong><strong>take</strong><strong> more </strong><strong>Glumine<sup>&reg;</sup></strong><strong> than you should </strong></p><p>If you happen to have taken too much <strong>Glumine<sup>&reg;</sup></strong> or an additional dose there is a danger of hypoglycaemia (signs of hypoglycaemia) and therefore you should instantly consume enough sugar (e.g. a small bar of sugar cubes, sweet juice, sweetened tea) and inform a doctor immediately. When treating hypoglycaemia due to accidental intake in children, the quantity of sugar given must be carefully controlled to avoid the possibility of producing dangerous hyperglycaemia. Persons in a state of unconsciousness must not be given food or drink. Since the state of hypoglycaemia may last for some time it is very important that the patient is carefully monitored until there is no more danger. Admission into hospital may be necessary, also as a measure of precaution. Show the doctor the package or remaining tablets, so the doctor knows what has been taken. Severe cases of hypoglycaemia accompanied by loss of consciousness and coma are cases of medical emergency requiring immediate medical treatment and admission into hospital. It may be helpful to tell your family and friends to call a doctor immediately if this happens to you.</p><p><strong>&nbsp;</strong></p><p><strong>If you </strong><strong>forget</strong><strong> to take Glumine<sup>&reg;</sup></strong></p><p>If you forget to take a dose, do not take a double dose to make up for forgotten doses.</p><p><strong>&nbsp;</strong></p><p><strong>If you stop taking Glumine<sup>&reg;</sup> </strong></p><p>If you interrupt or stop the treatment you should be aware that the desired blood sugar lowering effect is not achieved or that the disease will get worse again. Keep taking <strong>Glumine<sup>&reg;</sup></strong><sup> </sup>until your doctor tells you to stop.</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p><strong>Tell your doctor immediately if you experience any of the following symptoms:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergic reactions (including inflammation of blood vessels, often with skin rash) which may develop into serious reactions with difficulty in breathing, fall in blood pressure and sometimes progressing to shock</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Abnormal liver function including yellowing of the skin and eyes (jaundice), problems with the bile flow (cholestasis), inflammation of the liver (hepatitis) or liver failure</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergy (hypersensitivity) of the skin such as itching, rash, hives and increased sensitivity to sun. Some mild allergic reactions may develop into serious reactions</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe hypoglycaemia including loss of consciousness, seizures or coma</p><p>Some patients experienced the following side effects whilst taking glimepiride:</p><p><strong>Rare side effects</strong> (may affect up to 1 in 1,000 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lower blood sugar than normal (hypoglycaemia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Decrease in the number of blood cells:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blood platelets (which increases risk of bleeding or bruising)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; White blood cells (which makes infections more likely)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Red blood cells (which can make the skin pale and cause weakness or breathlessness)</p><p>These problems generally get better after you stop taking <strong>Glumine<sup>&reg;</sup></strong></p><p>Very rare side effects (may affect up to 1 in 10,000 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergic reactions (including inflammation of blood vessels, often with skin rash) which may develop into serious reactions with difficulty in breathing, fall in blood pressure and sometimes progressing to shock. If you experience any of these symptoms, tell your doctor immediately</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Abnormal liver function including yellowing of the skin and eyes (jaundice), impairment of the bile flow (cholestasis), inflammation of the liver (hepatitis) or liver failure. If you experience any of these symptoms, tell your doctor immediately</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling or being sick, diarrhoea, feeling full or bloated, and abdominal pain</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Decrease in the amount of sodium level in your blood (shown by blood tests) other side effects include:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergy (hypersensitivity) of the skin may occur such as itching, rash, hives and increased sensitivity to sun. Some mild allergic reactions may develop into serious reactions with swallowing or breathing problems, swelling of your lips, throat or tongue. Therefore in the event of one of these side effects, tell your doctor immediately</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergic reactions with sulfonylureas, sulfonamides, or related medicines may occur</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Problems with your sight may occur when beginning treatment with <strong>Glumine<sup>&reg;</sup></strong>. This is due to changes in blood sugar levels and should soon improve</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased liver enzymes</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe unusual bleeding or bruising under the skin</p><p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.</p><p>Do not use <strong>Glumine<sup>&reg;</sup></strong> after the expiry date which is stated on the carton. The expiry date refers to the last day of that month.</p><p>Do not store above 30&deg;C.</p><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance in <strong>Glumine<sup>&reg;</sup></strong> tablets is glimepiride. <strong>Glumine<sup>&reg;</sup></strong> tablets are available in four&nbsp; strengths 1mg, 2mg, 3mg and 4 mg tablets.</p><p>The other ingredients are lactose monohydrate, povidone, sodium starch glycolate, microcrystalline cellulose, magnesium stearate, red color (E172) in <strong>Glumine<sup>&reg;</sup></strong> 1 mg , yellow color (172) &amp; blue color (132) in <strong>Glumine<sup>&reg;</sup></strong> 2 mg, Yellow color (E172) in <strong>Glumine<sup>&reg;</sup></strong> 3 mg, Blue color (E132) in <strong>Glumine<sup>&reg;</sup></strong> 4 mg.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Glumine® tablets are capsule-shaped tablets.
Glumine® 1 mg tablets are pink , Glumine® 2 mg tablets are light green Glumine® 3 mg tablets are yellow and Glumine® 4 mg tablets are light blue. 
Glumine® tablets are packed in blisters of 15s. Glumine® is available in packs of 30 (2 bisters per pack). 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&nbsp;</p><p>Dar Al Dawa Development &amp; Investment Co Ltd (Na&rsquo;ur &ndash; Jordan).</p><p>Tel. (+962 6) 57 27 132</p><p>Fax. (+962 6) 57 27 776</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                04/2013
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>ان <strong>جلومين</strong> دواء يؤخذ عن طريق الفم ويساعد على خفض سكر الدم. ينتمي <strong>جلومين</strong> إلى مجموعة أدوية السلفونيل يوريا.</p><p>يعمل <strong>جلومين</strong> عن طريق زيادة كمية الأنسولين الذي يتم إفرازه من البنكرياس.</p><p>يقوم الأنسولين بخفض مستوى سكر الدم.</p><p><strong>ما هو إستخدام جلومين: </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; يستخدم <strong>جلومين</strong> لعلاج نوع معين من السكري (مرض السكري نوع 2) عند عجز الحمية الغذائية، التمارين الرياضية وخفض الوزن لوحدهم عن التحكم بمستوى السكر في الدم.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>موانع</strong><strong> </strong><strong>إستعمال </strong><strong>جلومين</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حساسية تجاه: جليميبرايد أو غيرها من ادوية السلفونيل يوريا (الأدوية التي تستخدم لخفض مستوى السكر في الدم مثل جليبينكلاميد) أو السلفوناميدات (المضادات الحيوية للبكتيريا مثل سلفاميثوكسازول) أو أي من المكونات الاخرى لهذا الدواء</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من السكري الذي يعتمد على الانسولين (مرض السكري نوع 1)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من الحماض الكيتوني السكري (احد مضاعفات مرض السكري عند إرتفاع مستوى الحمض في الجسم&nbsp; حيث قد تظهر العلامات التالية: تعب، شعور بتوعك (غثيان)، كثرة التبول وتصلب العضلات)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت في غيبوبة السكري</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من اعتلال شديد في الكلى</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من اعتلال شديد في الكبد &nbsp;</p><p>لا تأخذ هذا الدواء إذا إنطبق عليك اي من ما تم ذكره أعلاه</p><p>إذا كنت غير متأكدا، تحدث إلى طبيبك أو الصيدلي قبل أخذ <strong>جلومين</strong>.</p><p>&nbsp;</p><p><strong>الإحتياطات</strong><strong> </strong><strong>عند</strong><strong> </strong><strong>استعمال </strong><strong>جلومين</strong></p><p><strong>تحدث إلى طبيبك أو الصيدلي قبل أخذ هذا الدواء: </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تتعافى من إصابة، عملية جراحية، عدوى مع حمى، أو أشكال أخرى من الإجهاد، تحدث إلى طبيبك فقد تظهر حاجة لتغيير مؤقت للعلاج</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك إختلال حاد في الكبد أو الكلية</p><p>اذا كنت غير متاكد من ان أي من ما ذكر ينطبق عليك، تحدث إلى طبيبك أو الصيدلي قبل تناول <strong>جلومين</strong>.</p><p>قد يحدث إنخفاض في مستوى الهيموجلوبين وتكسر خلايا الدم الحمراء (فقر الدم الانحلالي) في مرضى عوز الجلوكوز -6-فوسفات النازع للهيدروجين.</p><p>البيانات المتوفرة عن إستخدام <strong>جلومين</strong> في الأشخاص الذين تقل أعمارهم عن 18 عام محدودة. ولذلك، لا ينصح بإستخدام هذا الدواء في هذه الفئة من المرضى.</p><p><strong>البيانات المتوافرة عن نقص سكر الدم </strong><strong>(</strong><strong>إنخفاض نسبة السكر في الدم</strong><strong>)</strong></p><p>من الممكن حدوث نقص في سكر الدم عند تناول <strong>جلومين</strong>. الرجاء قراءة المعلومات الإضافية المذكورة أدناه حول علامات وعلاج نقص سكر الدم.</p><p><strong>من الممكن أن يزيد خطر حدوث نقص سكر الدم بسبب وجود العوامل التالية: </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; نقص التغذية، عدم إنتظام وقت الوجبات، عدم تناول أو التأخر عن تناول وجبة الطعام أو خلال فترة الصيام</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; تغيير النظام الغذائي الخاص بك</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; تناول <strong>جلومين </strong>بجرعة اكبر من الجرعة اللازمة<strong>.</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; اختلال وظائف الكلى</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; مرض حاد في الكبد</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من إضطرابات معينة ناتجة عن الهرمونات (إضطرابات في الغدد الدرقية، الغدة النخامية أو قشرة الغدة الكظرية)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; شرب الكحول (وبخاصة عند تخطي وجبة الطعام)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; تناول بعض الأدوية</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا قمت بزيادة التمارين التي تقوم بها ولا تتناول كمية الغذاء الكافية أو تتناول وجبات غذائية تحتوي على كربوهيدرات أقل من اللازم.</p><p><strong>تتضمن علامات حدوث إنخفاض سكر الدم: </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; آلام ناتجة عن الجوع، صداع، غثيان، تقيؤ، ركود، نعاس، مشاكل في النوم، أرق، عدائية، مشاكل في التركيز، إنخفاض اليقظة وفترة رد الفعل، إكتئاب، إرتباك، مشاكل في الكلام والبصر، تداخل الكلام، إهتزاز، شلل جزئي، دوخة، عجز</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; قد تحدث العلامات التالية أيضا: تعرق، جلد رطب، قلق، زيادة سرعة أو زيادة ضربات القلب، إرتفاع ضغط الدم، الإحساس بضربات القلب، ألم قوي و مفاجئ في الصدر قد ينتشر إلى المناطق المجاورة (الذبحة الصدرية وعدم إنتظام ضربات القلب)</p><p>في حال إستمرار إنخفاض سكر الدم من الممكن أن تعاني من إرتباك (هذيان)، ظهور نوبات، فقدان السيطرة، قد يكون التنفس سطحي ويحدث تباطؤ في ضربات القلب، قد تقع في حالة فقدان للوعي. قد تشبه الصورة السريرية للإنخفاض الحاد في مستوى السكر في الدم السكتة الدماغية.</p><p><strong>علاج إنخفاض سكر الدم </strong></p><p>في معظم الحالات تختفي علامات إنخفاض سكر الدم بسرعة كبيرة عند إستهلاك بعض اشكال السكر، على سبيل المثال مكعبات السكر، عصير أو شاي محلى.</p><p>لذلك يجب أن يكون بحوزتك بعض السكريات (مثل مكعبات السكر). تذكر أن المحليات الإصطناعية ليست فعالة. يرجى الاتصال بطبيبك أو الذهاب إلى المستشفى في حال فشل السكر في المساعدة على تخطي الأعراض أو في حال تكرار الأعراض.</p><p><strong>الاختبارات المعملية</strong></p><p>يجب مراقبة مستوى السكر في الدم أو البول بإنتظام. قد يقوم طبيبك بإجراء فحوصات الدم لرصد خلايا الدم ووظائف الكبد.</p><p><strong>الأطفال والمراهقين</strong></p><p>لا ينصح تناول <strong>جلومين</strong> في الأطفال دون سن 18 عام.</p><p>&nbsp;</p><p><strong>التداخلات</strong><strong> </strong><strong>الدوائية</strong><strong> </strong><strong>من</strong><strong> </strong><strong>أخذ</strong><strong> </strong><strong>هذا</strong><strong> </strong><strong>المستحضر</strong><strong> </strong><strong>مع</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>أدوية</strong><strong> </strong><strong>أخرى</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>أعشاب</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>مكملات</strong><strong> </strong><strong>غذائية</strong></p><p>أخبر طبيبك أو الصيدلي في حال تناولت مؤخرا أو قد تأخذ أي أدوية أخرى.</p><p>قد يرغب طبيبك بتغيير جرعة <strong>جلومين</strong> إذا كنت تأخذ أدوية أخرى، والتي قد تضعف أو تعزز تأثير <strong>جلومين</strong> على مستوى السكر في دمك.</p><p>قد تزيد الأدوية التالية تأثير <strong>جلومين</strong> &nbsp;الخافض لسكر الدم وتقلل تأثير <strong>جلومين</strong>. قد يؤدي إلى خطر نقص سكر الدم.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية الأخرى لعلاج مرض السكري (مثل الإنسولين أو المتفورمين)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لتخفيف الألم وعلاج الإلتهاب (الأدوية مثل فنيل بوتازون، آزابروبازون، أوكسي فينبيوتازون، الأسبرين والادوية المماثلة له)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لعلاج إلتهابات المسالك البولية (مثل بعض السلفوناميدات طويلة المفعول)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لعلاج الإلتهابات البكتيرية والفطرية (تتراسكلين، كلورامفينيكول، فلوكونازول، ميكونازول، الكينولونات، كلاريثرومايسين)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لمنع تخثر الدم (مشتقات الكومارين مثل وارفارين)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية الداعمة لبناء العضلات (إبتنائيات)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; أدوية الهرمونات البديلة للهرمونات الذكرية</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لعلاج الإكتئاب (فلوكستين، مثبطات مونو أمينو أوكسيداز)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لخفض فرط مستوى الكوليسترول (فايبريت)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لخفض فرط ضغط الدم (مثبط الإنزيم المحول للأنجيوتنسين)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; أدوية مضادات إضطراب النظم التي تستخدم للتحكم في ضربات القلب غير الطبيعية (ديسوبيراميد)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لعلاج النقرس (الوبيورينول، بروبينسيد، سلفينبايرازون)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لعلاج السرطان (سيكلوفوسفاميد، ايفوفوسفاميد، تروفوسفاميد)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لخفض الوزن (فينفلورامين)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لزيادة الدورة الدموية عند إعطائها بجرعة عالية عن طريق التسريب في الوريد (بنتوكسيفيلين)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لعلاج الحساسية الأنفية مثل حمى القش (تريتوكوالين)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية داحضة الودية التي تستخدم لعلاج إرتفاع ضغط الدم، فشل القلب أو أعراض البروستات</p><p>من الممكن أن تقلل الأدوية التالية من تأثير <strong>جلومين</strong> الخافض لسكر الدم. مما يؤدي إلى خطر حدوث إرتفاع سكر الدم.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تحتوي على الهرمونات التناسلية الأنثوية (إستروجين، بروجسترون)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لعلاج إرتفاع ضغط الدم والتي تسمى بمدرات البول الثيازيدية</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لتحفيز الغدة الدرقية (مثل ليفوثيروكسين)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لعلاج الحساسية والإلتهاب (غلوكوكوريتكويدات)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لعلاج الإضطرابات النفسية الحادة (مشتقات الكلوربرومازين ومشتقات الفينوثيازين الأخرى)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لزيادة ضربات القلب، علاج الربو أو احتقان الأنف، سعال ونزلات البرد، خفض الوزن، أو الأدوية التي تستخدم في حالات الطوارئ المهددة للحياة (الأدرينالين ومحاكيات الودية)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لخفض مستوى الكوليسترول المرتفع (حامض النيكوتينيك)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لعلاج الإمساك عند الإستخدام طويل الأمد (الملينات)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لعلاج النوبات (فينيتوين)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لعلاج مشاكل العصبية والنوم (باربيتورات)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لعلاج فرط ضغط الدم في العين (استازولاميد)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لعلاج إرتفاع ضغط الدم أو خفض السكر في الدم (ديازوكسيد)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لعلاج الإلتهابات، السل (ريفامبيسين)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لعلاج الإنخفاض الحاد في مستوى السكر في الدم (جلوكاجون)</p><p>قد تزيد الأدوية التالية أو تقلل تأثير <strong>جلومين</strong> الخافض للسكر في الدم:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لعلاج قرحة المعدة (تسمى مضادات H2 )</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لعلاج إرتفاع ضغط الدم أو فشل القلب مثل حاصرات بيتا، كلونيدين ،غوانيثيدين وريزيربين. من الممكن أن تخفي هذه الأدوية علامات إنخفاض سكر الدم، يجب توخي الحذر عند أخذ هذه الأدوية</p><p>قد يزيد أو يضعف <strong>جلومين</strong> تأثيرات الأدوية التالية:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تمنع تخثر الدم (مشتقات الكومارين مثل الوارفارين).</p><p>&nbsp;</p><p><strong>تناول جلومين</strong><strong> </strong><strong>مع</strong><strong> </strong><strong>الطعام</strong><strong> </strong><strong>والشراب</strong></p><p>من الممكن أن يزيد أو يقلل الكحول من فعالية <strong>جلومين</strong> في خفض سكر الدم بطريقة غير معروفة.</p><p>&nbsp;</p><p><strong>الحمل</strong><strong> </strong><strong>والرضاعة</strong></p><p><strong>الحمل</strong></p><p>يمنع إستخدام <strong>جلومين</strong> خلال الحمل. أخبري طبيبك في حال الشك بوجود حمل أو تخططين لحدوث حمل.</p><p><strong>الرضاعة </strong></p><p>قد يفرز <strong>جلومين</strong> في لبن الأم المرضعة. يمنع إستخدام <strong>جلومين</strong> خلال الرضاعة.</p><p>إستشر طبيبك أو الصيدلي قبل تناول أي دواء.</p><p>&nbsp;</p><p><strong>تأثير </strong><strong>جلومين</strong><strong> على القيادة وإستخدام الآلات</strong></p><p>من الممكن أن تنخفض قدرتك على التركيز أو تتأثر ردود افعالك عند إنخفاض نسبة السكر في الدم، أو عند فرط سكر الدم أو في حال ظهرت لديك مشاكل في البصر نتيجة هذه الظروف. يجب الأخذ بالإعتبار انه قد تشكل خطرا على نفسك والاخرين عند قيادتك للمركبات او استخدام الالات.إسأل الطبيب إذا كان بإمكانك قيادة السيارة:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حال كان لديك نوبات متكررة من إنخفاض سكر الدم</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حال لم تظهر لديك اعراض انخفاض سكر الدم او ظهرت بشكل اقل تكرارا.</p><p>&nbsp;</p><p><strong>معلومات هامة حول بعض مكونات </strong><strong>جلومين</strong></p><p>تحتوي أقراص <strong>جلومين </strong>على اللاكتوز، استشر طبيبك قبل اخذ هذا الدواء إذا أخبرك أن ليس لديك قدرة على تحمل بعض السكريات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>تناول هذا الدواء تماما كما وصفه الطبيب لك. يجب التأكد من الطبيب أو الصيدلي إذا لم تكن متأكدا.</p><p><strong>تناول هذا الدواء: </strong></p><p><strong>كيفية تناول الدواء</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يؤخذ هذا الدواء عن طريق الفم قبل وجبة الطعام الأولى بقليل أو مع وجبة الطعام الأولى (عادة وجبة الإفطار). إذا لم تتناول وجبة الإفطار يجب أخذ الدواء على برنامج يضعه طبيبك. من المهم عدم إهمال أي وجبة طعام عند تناول <strong>جلومين</strong>.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تناول الأقراص مع نصف كوب من الماء على الأقل. لا تقم بمضغ أو سحق الأقراص.</p><p><strong>كمية الدواء الموصى باخذه</strong></p><p>تعتمد الجرعة الموصى بها على الحاجة، الحالة ونتائج فحص الدم والسكر في البول ويتم تحديدها من قبل طبيبك المعالج. لا تأخذ أكثر من الجرعة الموصى بها.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجرعة الإعتيادية الابتدائية هي قرص واحد من <strong>جلومين</strong> 1 ملغم مرة واحدة يوميا.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; من الممكن أن يقوم طبيبك بزيادة الجرعة بعد اسبوع الى اسبوعين من العلاج.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجرعة اليومية القصوى الموصى بها هي 6 ملغم <strong>جلومين</strong>.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; من الممكن أن يبدأ الطبيب العلاج بالتزامن بين جليميبرايد ومتفورمين أو جليميبرايد والإنسولين. في هذه الحالة سوف يقوم طبيبك بتحديد الجرعة الملائمة من جليميبرايد، متفورمين أو الإنسولين كل على حدى.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; من الممكن أن تظهر حاجة لتعديل الجرعة إذا حدث تغير في الوزن لديك، تغيير نمط الحياة، أو إذا كنت تمر بضغوطات. تحدث إلى طبيبك إذا إنطبق عليك أي من ما تم ذكره.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا شعرت أن تأثير الدواء ضعيف جدا أو قوي جدا لا تغير الجرعة من تلقاء نفسك وإستشر الطبيب.</p><p>&nbsp;</p><p><strong>الجرعة</strong><strong> </strong><strong>الزائدة</strong><strong> </strong><strong>من</strong><strong> </strong><strong>جلومين</strong></p><p>في حال تناولت جرعة زائدة من <strong>جلومين</strong> أو جرعة اضافية يزيد خطر حدوث إنخفاض سكر الدم (علامات إنخفاض سكر الدم) وبالتالي يجب أن تستهلك كميات كافية من السكر (على سبيل المثال شريط صغير من مكعبات السكر، عصير محلى، شاي محلى) وقم بإبلاغ الطبيب على الفور. في حال تناول طفل للدواء عن طريق الخطأ حيث انه يجب ان تكون كمية السكر التي تعطيها للطفل محددة بعناية لتجنب مخاطر حدوث فرط سكر الدم. يمنع إعطاء الشخص الفاقد للوعي الطعام أو الشراب. لان إنخفاض سكر الدم قد يستمر لفترة من الزمن فانه من الهام مراقبة المريض بحذر لحين زوال الخطر. من الممكن أن تظهر حاجة للدخول إلى المستشفى وقد يلزم ذلك كاجراء احتياطي. أظهر للطبيب العبوة الخارجية أو الأقراص المتبقية ليعرف ما هو الدواء الذي قمت بتناوله. الحالات الخطرة من إنخفاض سكر الدم تترافق مع فقدان الوعي وغيبوبة هي حالات طبية طارئة تحتاج إلى علاج طبي على الفور والدخول إلى المستشفى. من المفيد أن تخبر أحد أفراد عائلتك أو أصدقائك لإبلاغ الطبيب على الفور إذا حدث ذلك.</p><p>&nbsp;</p><p><strong>نسيان</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>جرعة</strong><strong> </strong><strong>جلومين</strong></p><p>إذا نسيت تناول جرعة، لا تقم بمضاعفة الجرعة للتعويض عن الجرعة الفائتة.</p><p>&nbsp;</p><p><strong>التوقف عن تناول </strong><strong>جلومين</strong></p><p>في حال قمت بقطع أو التوقف عن تناول العلاج يجب أن تدرك أن الإنخفاض المرغوب به في سكر الدم لم يتم تحقيقه وأن المرض قد يتفاقم مرة أخرى. يجب أن تستمر بأخذ <strong>جلومين</strong> الى ان يطلب طبيبك ان تتوقف عن تناول الدواء.</p><p>إذا كانت لديك أي أسئلة تتعلق بإستخدام هذا الدواء اسال طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>شأنه شأن الأدوية الأخرى قد ينتج عن تناول الدواء أعراض جانبية، على الرغم من أنها لا تحدث مع جميع المرضى.</p><p>أخبر طبيبك على الفور إذا ظهرت اي من الأعراض الجانبية التالية:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات حساسية (والتي تتضمن إلتهابات الأوعية الدموية غالبا مع طفح جلدي) والتي من الممكن أن تتطور إلى تفاعلات حادة مع صعوبة في التنفس، إنخفاض ضغط الدم أو في بعض الأحيان التطور إلى صدمة.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اختلال وظائف الكبد يتضمن إصفرار الجلد والعينين (يرقان)، مشاكل في تدفق الصفراء (ركود صفراوي)، إلتهاب الكبد أو فشل الكبد.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات حساسية في الجلد مثل حكة، شرى وزيادة الحساسية تجاه الشمس. بعض التفاعلات من الممكن أن تتطور إلى تفاعلات حادة.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إنخفاض سكر الدم الحاد تتضمن فقدان الوعي، نوبات أو غيبوبة.</p><p>الأعراض الجانبية النادرة (من الممكن أن يؤثر على 1 في 1000 شخص)</p><p>قد تظهر الاثار الجانبية التالية لدى تناول <strong>جلومين</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إنخفاض السكر في الدم بشكل أكبر من الطبيعي (إنخفاض سكر الدم)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إنخفاض عدد خلايا الدم</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصفائح الدموية (التي تزيد خطر النزف و الكدمات)</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كريات الدم البيضاء (زيادة إحتمالية حدوث عدوى)</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كريات الدم الحمراء (من الممكن أن تعمل على التسبب بشحوب البشرة وضعف أو صعوبة &nbsp;في التنفس)</p><p>يحدث تحسن في هذه الأعراض بعد التوقف عن تناول <strong>جلومين</strong>.</p><p>أعراض جانبية نادرة جدا (من الممكن أن تؤثر بحد اعلى على 1 من كل 10000 شخص)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات حساسية (تتضمن حدوث إلتهاب في الأوعية الدموية غالبا مع طفح جلدي) والتي من الممكن أن تتطور إلى تفاعلات حادة مع صعوبة في التنفس، إنخفاض ضغط الدم وفي بعض الأحيان التطور إلى صدمة. إذا إختبرت أي من هذه الأعراض تحدث إلى طبيبك على الفور</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وظائف الكبد غير الطبيعية تتضمن إصفرار الجلد والعينين (يرقان)، إختلال في تدفق الصفراء (ركود صفراوي)، إلتهاب الكبد أو فشل الكبد، إذا إختبرت أي من هذه الأعراض تحدث إلى طبيبك على الفور</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإحساس بحدوث أو حدوث إعياء، إسهال، الشعور بالإمتلاء أو الإنتفاخ وألم في البطن</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إنخفاض كمية الصوديوم في الدم (تظهر في فحص الدم) تتضمن الأعراض الجانبية حدوث:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات حساسية في الجلد مثل حكة، طفح، شرى وزيادة في الحساسية تجاه الشمس. من الممكن أن تتطور بعض تفاعلات الحساسية المعتدلة إلى تفاعلات حادة مع صعوبة في البلع والتنفس، إنتفاخ الشفاه، الحلق، اللسان. لذلك أخبر طبيبك إذا حدث لديك أحد هذه الأعراض الجانبية على الفور.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد تحدث تفاعلات حساسية مع السلفونيل يوريا، سلفوناميدات، أو الأدوية ذات الصلة</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يحدث لديك مشاكل في البصر عند بداية العلاج. ويعود ذلك إلى حدوث تغيرات في مستوى السكر في الدم وينبغي أن يحدث تحسن قريب</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع في إنزيمات الكبد</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نزيف شديد غير إعتيادي أو كدمات شديدة تحت الجلد</p><p>إذا كان لديك أي أعراض جانبية تحدث إلى طبيبك أو الصيدلي. يتضمن ذلك أي من الأعراض الجانبية المحتملة الغير المدرجة في هذه النشرة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ <strong>جلومين</strong> بعيدا عن متناول ايدي الاطفال.</p><p>لا تستخدم <strong>جلومين</strong> بعد تاريخ الانتهاء المذكور على العبوة الخارجية. يدل تاريخ الانتهاء على اخر يوم في الشهر المذكور.</p><p>يحفظ على حرارة لا تزيد عن 30 درجة مئوية.</p><p>يجب عدم التخلص من الأدوية في المياه العادمة أو النفايات المنزلية. إسأل الصيدلي حول الطريقة السليمة للتخلص من الأدوية التي لم تعد بحاجة إليها. سيساعد هذا في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>ما هي</strong><strong> </strong><strong>محتويات </strong><strong>جلومين</strong></p><p>المادة الفعالة في اقراص <strong>جلومين</strong> هي جليميبرايد. اقراص <strong>جلومين </strong>متوفرة باربع تراكيز 1 ملغم، 2 ملغم، 3 ملغم و 4 ملغم<strong>. </strong>&nbsp;</p><p>المواد غير الفعالة الأخرى هي لاكتوز أحادي الماء، بوفيدون، أملاح الصوديوم لجليكولات النشا، سيليلوز دقيق البلورية، ستيارات الماغنيسيوم، لون أحمر E172)) في <strong>جلومين</strong> 1 ملغم، لون أصفر E172)) ولون أزرق ((E132 في <strong>جلومين</strong> 2 ملغم، لون أصفر E172)) في <strong>جلومين</strong> 3 ملغم ولون أزرق ((E132 في اقراص <strong>جلومين</strong> 4 ملغم.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            ما هو الشكل الصيدلاني لجلومين ووصفه وحجم عبوته.
اقراص جلومين هي اقراص على شكل كبسولة. 
جلومين 1 ملغم أقراص وردية اللون على شكل الكبسولة، جلومين 2 ملغم أقراص ذات لون أخضر فاتح ، اقراص جلومين 3 ملغم صفراء اللون بينما اقراص جلومين 4 ملغم ذات لون ازرق فاتح. 
اقراص جلومين مغلفة في اشرطة يحتوي كل شريط على 15 قرص  في كل عبوة  جلومين  30 قرص (شريطين).

        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>شركة دار الدواء للتنمية والإستثمار المساهمة المحدودة (ناعور- الأردن)</p><p>&nbsp;(+ 962 6) 57 27 132&nbsp; هاتف</p><p>&nbsp;(+ 962 6) 57 27 776 فاكس</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            04/2013
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Glumine® tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Glumine® 1 tablets: Packs of 30,500 tablets. Each tablet contains 1 mg glimepiride.
Glumine® 2 tablets: Packs of 30,500 tablets. Each tablet contains 2 mg glimepiride.
Glumine® 3 tablets: packs of 30,500 tablets. Each tablet contains 3 mg glimepiride. 
Glumine® 4 tablets: packs of 30,500 tablets. Each tablet contains 4 mg glimepiride.
For a full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Tablets.
	Glumine® 1 mg tablets are pink capsule - shaped tablets with a mid-groove on both sides. Coded (DIA 1) on one side.
	Glumine® 2 mg tablets are light green capsule - shaped tablets with a mid-groove on both sides. Coded (DIA 2) on one side.
	Glumine® 3 mg tablets are yellow capsule - shaped tablet with a mid-groove on both sides. Coded (DIA 3) on one side.
	Glumine® 4 mg tablets are light blue capsule-shaped tablet with a mid-groove on both sides. Coded (DIA 4) on one side.
Glumine® tablets are available in packs of 30 (2 blisters of 15) and 500 (50 blisters of 10).


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Glumine</strong><strong><sup>&reg; </sup></strong>is indicated for the treatment of type 2 diabetes mellitus, when diet, physical exercise and weight reduction alone are not adequate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellpadding="0" style="width:100%"><tbody><tr><td>&nbsp;</td><td><p>For oral administration</p><p>The basis for successful treatment of diabetes is a good diet, regular physical activity, as well as routine checks of blood and urine. Tablets or insulin cannot compensate if the patient does not keep to the recommended diet.</p><p><u>Posology</u></p><p>Dose is determined by the results of blood and urinary glucose determinations.</p><p>The starting dose is 1 mg glimepiride per day. If good control is achieved this dose should be used for maintenance therapy.</p><p>For the different dose regimens appropriate strengths are available.</p><p>If control is unsatisfactory the dose should be increased, based on the glycaemic control, in a stepwise manner with an interval of about 1 to 2 weeks between each step, to 2, 3 or 4 mg glimepiride per day.</p><p>A dose of more than 4 mg glimepiride per day gives better results only in exceptional cases. The maximum recommended dose is 6 mg glimepiride per day.</p><p>In patients not adequately controlled with the maximum daily dose of metformin, concomitant glimepiride therapy can be initiated.</p><p>While maintaining the metformin dose, the glimepiride therapy is started with a low dose, and is then titrated up depending on the desired level of metabolic control up to the maximum daily dose. The combination therapy should be initiated under close medical supervision.</p><p>In patients not adequately controlled with the maximum daily dose of glimepiride, concomitant insulin therapy can be initiated if necessary. While maintaining the glimepiride dose, insulin treatment is started at low dose and titrated up depending on the desired level of metabolic control. The combination therapy should be initiated under close medical supervision.</p><p>Normally a single daily dose of glimepiride is sufficient. It is recommended that this dose be taken shortly before or during a substantial breakfast or - if none is taken - shortly before or during the first main meal.</p><p>If a dose is forgotten, this should not be corrected by increasing the next dose.</p><p>If a patient has a hypoglycaemic reaction on 1 mg glimepiride daily, this indicates that they can be controlled by diet alone.</p><p>In the course of treatment, as an improvement in control of diabetes is associated with higher insulin sensitivity, glimepiride requirements may fall. To avoid hypoglycaemia timely dose reduction or cessation of therapy must therefore be considered. Change in dose may also be necessary, if there are changes in weight or life style of the patient, or other factors that increase the risk of hypo-or hyperglycaemia.</p><p><em>Switch over from other oral hypoglycaemic agents to <strong>Glumine</strong></em><strong><sup>&reg;</sup></strong></p><p>A switch over from other oral hypoglycaemic agents to <strong>Glumine<sup>&reg;</sup></strong> can generally be done. For the switch over to <strong>Glumine<sup>&reg; </sup></strong>the strength and the half-life of the previous medicinal product has to be taken into account. In some cases, especially in antidiabetics with a long half-life (e.g. chlorpropamide), a wash out period of a few days is advisable in order to minimise the risk of hypoglycaemic reactions due to the additive effect.</p><p>The recommended starting dose is 1 mg glimepiride per day. Based on the response the glimepiride dose may be increased stepwise, as indicated earlier.</p><p><em>Switch over from Insulin to <strong>Glumine</strong></em><strong><sup>&reg;</sup></strong></p><p>In exceptional cases, where type 2 diabetic patients are regulated on insulin, a changeover to <strong>Glumine<sup>&reg;</sup></strong> may be indicated. The changeover should be undertaken under close medical supervision.</p><p><em>Special Populations</em></p><p>Patients with renal or hepatic impairment:</p><p>See section 4.3.</p><p>Paediatric population:</p><p>There are no data available on the use of glimepiride in patients under 8 years of age. For children aged 8 to 17 years, there are limited data on glimepiride as monotherapy (see sections 5.1 and 5.2).</p><p>The available data on safety and efficacy are insufficient in the paediatric population and therefore such use is not recommended.</p><p><u>Method of administration</u></p><p>Tablets should be swallowed without chewing with some liquid.</p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Glimepiride is contraindicated in patients with the following conditions:
• hypersensitivity to glimepiride, other sulfonylureas or sulfonamides or to any of the excipients listed in section 6.1 
• insulin dependent diabetes, 
• diabetic coma, 
• ketoacidosis, 
• severe renal or hepatic function disorders. In case of severe renal or hepatic function disorders, a change over to insulin is required.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Glumine<sup>&reg;</sup></strong> must be taken shortly before or during a meal.</p><p>When meals are taken at irregular hours or skipped altogether, treatment with <strong>Glumine<sup>&reg; </sup></strong>may lead to hypoglycaemia. Possible symptoms of hypoglycaemia include: headache, ravenous hunger, nausea, vomiting, lassitude, sleepiness, disordered sleep, restlessness, aggressiveness, impaired concentration, alertness and reaction time, depression, confusion, speech and visual disorders, aphasia, tremor, paresis, sensory disturbances, dizziness, helplessness, loss of self-control, delirium, cerebral convulsions, somnolence and loss of consciousness up to and including coma, shallow respiration and bradycardia. In addition, signs of adrenergic counter-regulation may be present such as sweating, clammy skin, anxiety, tachycardia, hypertension, palpitations, angina pectoris and cardiac arrhythmias.</p><p>The clinical picture of a severe hypoglycaemic attack may resemble that of a stroke.</p><p>Symptoms can almost always be promptly controlled by immediate intake carbohydrates (sugar). Artificial sweeteners have no effect.</p><p>It is known from other sulfonylureas that, despite initially successful countermeasures, hypoglycaemia may recur.</p><p>Severe hypoglycaemia or prolonged hypoglycaemia, only temporarily controlled by the usual amounts of sugar, require immediate medical treatment and occasionally hospitalisation.</p><p>Factors favouring hypoglycaemia include:</p><p>- unwillingness or (more commonly in older patients) incapacity of the patient to cooperate,</p><p>- undernutrition, irregular mealtimes or missed meals or periods of fasting,</p><p>- alterations in diet,</p><p>- imbalance between physical exertion and carbohydrate intake,</p><p>- consumption of alcohol, especially in combination with skipped meals,</p><p>- impaired renal function,</p><p>- serious liver dysfunction,</p><p>- overdose with <strong>Glumine<sup>&reg;</sup></strong>,</p><p>- certain uncompensated disorders of the endocrine system affecting carbohydrate metabolism or counter-regulation of hypoglycaemia (as for example in certain disorders of thyroid function and in anterior pituitary or adrenocortical insufficiency),</p><p>- concurrent administration of certain other medicinal products (see section 4.5).</p><p>Treatment with <strong>Glumine<sup>&reg; </sup></strong>requires regular monitoring of glucose levels in blood and urine. In addition determination of the proportion of glycosylated haemoglobin is recommended.</p><p>Regular hepatic and haematological monitoring (especially leucocytes and thrombocytes) are required during treatment with <strong>Glumine<sup>&reg;</sup></strong>.</p><p>In stress-situations (e.g. accidents, acute operations, infections with fever, etc.) a temporary switch to insulin may be indicated.</p><p>No experience has been gained concerning the use of glimepiride in patients with severe impairment of liver function or dialysis patients. In patients with severe impairment of renal or liver function change over to insulin is indicated.</p><p>Treatment of patients with G6PD-deficiency with sulfonylurea agents can lead to hemolytic anaemia. Since glimepiride belongs to the class of sulfonylurea agents, caution should be used in patients with G6PD-deficiency and a non-sulfonylurea alternative should be considered.</p><p><strong>Glumine<sup>&reg;</sup></strong> contains lactose monohydrate. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>If glimepiride is taken simultaneously with certain other medicinal products, both undesired increases and decreases in the hypoglycaemic action of glimepiride can occur. For this reason, other medicinal products should only be taken with the knowledge (or at the prescription) of the doctor.</p><p>Glimepiride is metabolized by cytochrome P450 2C9 (CYP2C9). Its metabolism is known to be influenced by concomitant administration of CYP2C9 inducers (e.g. rifampicin) or inhibitors (e.g. fluconazole).</p><p>Results from an <em>in vivo</em> interaction study reported in literature show that glimepiride AUC is increased approximately 2-fold by fluconazole, one of the most potent CYP2C9 inhibitors.</p><p>Based on the experience with glimepiride and with other sulfonylureas the following interactions have to be mentioned.</p><p>Potentiation of the blood-glucose-lowering effect and, thus, in some instances hypoglycaemia may occur when one of the following medicinal products is taken, for example:</p><p>- phenylbutazone, azapropazone and oxyfenbutazone,</p><p>- insulin and oral antidiabetic products, such as metformin,</p><p>- salicylates and p-amino-salicylic acid,</p><p>- anabolic steroids and male sex hormones,</p><p>- chloramphenicol, certain long acting sulfonamides, tetracyclines, quinolone antibiotics and clarithromycin</p><p>- coumarin anticoagulants,</p><p>- fenfluramine,</p><p>- disopyramide,</p><p>- fibrates,</p><p>- ACE inhibitors,</p><p>- fluoxetine, MAO-inhibitors</p><p>- allopurinol, probenecid, sulfinpyrazone,</p><p>- sympatholytics,</p><p>- cyclophosphamide, trophosphamide and iphosphamides,</p><p>- miconazole, fluconazole,</p><p>- pentoxifylline (high dose parenteral),</p><p>- tritoqualine.</p><p>Weakening of the blood-glucose-lowering effect and, thus raised blood glucose levels may occur when one of the following medicinal products is taken, for example:</p><p>- oestrogens and progestogens,</p><p>- saluretics, thiazide diuretics,</p><p>- thyroid stimulating agents, glucocorticoids,</p><p>- phenothiazine derivatives, chlorpromazine,</p><p>- adrenaline and sympathicomimetics,</p><p>- nicotinic acid (high doses) and nicotinic acid derivatives,</p><p>- laxatives (long term use),</p><p>- phenytoin, diazoxide,</p><p>- glucagon, barbiturates and rifampicin,</p><p>- acetazolamide.</p><p>H<sub>2</sub> antagonists, beta-blockers, clonidine and reserpine may lead to either potentiation or weakening of the blood-glucose-lowering effect.</p><p>Under the influence of sympatholytic medicinal products such as beta-blockers, clonidine, guanethidine and reserpine, the signs of adrenergic counter-regulation to hypoglycaemia may be reduced or absent.</p><p>Alcohol intake may potentiate or weaken the hypoglycaemic action of glimepiride in an unpredictable fashion.</p><p>Glimepiride may either potentiate or weaken the effects of coumarin derivatives.</p><p>Colesevelam binds to glimepiride and reduces glimepiride absorption from the gastro-intestinal tract. No interaction was observed when glimepiride was taken at least 4 hours before colesevelam. Therefore, glimepiride should be administered at least 4 hours prior to colesevelam.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>Pregnancy category C</p><p><em>Risk related to the diabetes</em></p><p>Abnormal blood glucose levels during pregnancy are associated with a higher incidence of congenital abnormalities and perinatal mortality. So the blood glucose level must be closely monitored during pregnancy in order to avoid the teratogenic risk. The use of insulin is required under such circumstances. Patients who consider pregnancy should inform their physician.</p><p><em>Risk related to glimepiride</em></p><p>There are no adequate data from the use of glimepiride in pregnant women. Animal studies have shown reproductive toxicity which likely was related to the pharmacologic action (hypoglycaemia) of glimepiride (see section 5.3).</p><p>Consequently, glimepiride should not be used during the whole pregnancy.</p><p>In case of treatment by glimepiride, if the patient plans to become pregnant or if a pregnancy is discovered, the treatment should be switched as soon as possible to insulin therapy.</p><p><u>Lactation</u></p><p>The excretion in human milk is unknown. Glimepiride is excreted in rat milk. As other sulfonylureas are excreted in human milk and because there is a risk of hypoglycaemia in nursing infants, breast-feeding is advised against during treatment with glimepiride.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies on the effects on the ability to drive and use machines have been performed.</p><p>The patient&#39;s ability to concentrate and react may be impaired as a result of hypoglycaemia or hyperglycaemia or, for example, as a result of visual impairment. This may constitute a risk in situations where these abilities are of special importance (e.g. driving a car or operating machinery).</p><p>Patients should be advised to take precautions to avoid hypoglycaemia whilst driving. This is particularly important in those who have reduced or absent awareness of the warning symptoms of hypoglycaemia or have frequent episodes of hypoglycaemia. It should be considered whether it is advisable to drive or operate machinery in these circumstances.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following adverse reactions from clinical investigations were based on experience with glimipiride and other sulfonylureas, were listed below by system organ class and in order of decreasing incidence (very common: &ge;1/10; common: &ge;1/100 to &lt;1/10; uncommon: &ge;1/1,000 to &lt;1/100; rare: &ge;1/10,000 to &lt;1/1,000; very rare: &lt;1/10,000), not known (cannot be estimated from the available data).</p><p><u>Blood and lymphatic system disorders</u></p><p>Rare: thrombocytopenia, leukopenia, granulocytopenia, agranulocytosis, erythropenia, haemolytic anaemia and pancytopenia, which are in general reversible upon discontinuation of medication. Not known: severe thrombocytopenia with platelet count less than 10,000/&micro;l and thrombocytopenic purpura.</p><p><u>Immune system disorders</u></p><p>Very rare: leukocytoclastic vasculitis, mild hypersensitivity reactions that may develop into serious reactions with dyspnoea, fall in blood pressure and sometimes shock.</p><p>Not-known: cross-allergenicity with sulfonylureas, sulfonamides or related substances is possible.</p><p><u>Metabolism and nutrition disorders</u></p><p>Rare: hypoglycaemia.</p><p>These hypoglycaemic reactions mostly occur immediately, may be severe and are not always easy to correct. The occurrence of such reactions depends, as with other hypoglycaemic therapies, on individual factors such as dietary habits and dose (see further under section 4.4).</p><p><u>Eye disorders</u></p><p>Not known: visual disturbances, transient, may occur especially on initiation of treatment, due to changes in blood glucose levels.</p><p><u>Gastrointestinal disorders</u></p><p>Very rare<em>:</em> nausea, vomiting, diarrhoea, abdominal distension, abdominal discomfort and abdominal pain, which seldom lead to discontinuation of therapy.</p><p><u>Hepato-biliary disorders</u></p><p>Not know: hepatic enzymes increased.</p><p>Very rare<em>:</em> hepatic function abnormal (e.g. with cholestasis and jaundice), hepatitis and hepatic failure.</p><p><u>Skin and subcutaneous tissue disorders</u></p><p>Not known: hypersensitivity reactions of the skin may occur as pruritus, rash, urticaria and photosensitivity.</p><p><u>Investigations</u></p><p>Very rare: blood sodium decrease.</p><p><strong>To report any side effects:</strong></p><p><strong>National Pharmacovigilance and Drug Safety Centre (NPC)</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fax: + 966 112057662</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Call NPC at + 966 112038222, Exts: 2317-2356-2353-2354-2334-2340</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Toll free phone: 8002490000</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: www.sfda.gov.sa/npc</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellpadding="0" style="width:100%"><tbody><tr><td><p><u>Symptoms</u></p><p>After ingestion of an overdose hypoglycaemia may occur, lasting from 12 to 72 hours, and may recur after an initial recovery. Symptoms may not be present for up to 24 hours after ingestion. In general observation in hospital is recommended. Nausea, vomiting and epigastric pain may occur. The hypoglycaemia may in general be accompanied by neurological symptoms like restlessness, tremor, visual disturbances, co-ordination problems, sleepiness, coma and convulsions.</p><p>Management</p><p>Treatment primarily consists of preventing absorption by inducing vomiting and then drinking water or lemonade with activated charcoal (adsorbent) and sodium-sulphate (laxative). If large quantities have been ingested, gastric lavage is indicated, followed by activated charcoal and sodium-sulphate. In case of (severe) overdose hospitalisation in an intensive care department is indicated. Start the administration of glucose as soon as possible, if necessary by a bolus intravenous injection of 50 ml of a 50% solution, followed by an infusion of a 10% solution with strict monitoring of blood glucose. Further treatment should be symptomatic.</p><p>In particular when treating hypoglycaemia due to accidental intake of glimepiride in infants and young children, the dose of glucose given must be carefully controlled to avoid the possibility of producing dangerous hyperglycaemia. Blood glucose should be closely monitored.</p></td><td>&nbsp;</td></tr></tbody></table><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Blood glucose lowering drugs, excl. insulins: Sulfonamides, urea derivatives. ATC Code: A10B B12.</p><p>Glimepiride is an orally active hypoglycaemic substance belonging to the sulfonylurea group. It may be used in non-insulin dependent diabetes mellitus.</p><p>Glimepiride acts mainly by stimulating insulin release from pancreatic beta cells.</p><p>As with other sulfonylureas this effect is based on an increase of responsiveness of the pancreatic beta cells to the physiological glucose stimulus. In addition, glimepiride seems to have pronounced extrapancreatic effects also postulated for other sulfonylureas.</p><p><u>Insulin release</u></p><p>Sulfonylureas regulate insulin secretion by closing the ATP-sensitive potassium channel in the beta cell membrane. Closing the potassium channel induces depolarisation of the beta cell and results - by opening of calcium channels - in an increased influx of calcium into the cell.</p><p>This leads to insulin release through exocytosis.</p><p>Glimepiride binds with a high exchange rate to a beta cell membrane protein which is associated with the ATP-sensitive potassium channel but which is different from the usual sulfonylurea binding site.</p><p><u>Extrapancreatic activity</u></p><p>The extrapancreatic effects are for example an improvement of the sensitivity of the peripheral tissue for insulin and a decrease of the insulin uptake by the liver.</p><p>The uptake of glucose from blood into peripheral muscle and fat tissues occurs via special transport proteins, located in the cells membrane. The transport of glucose in these tissues is the rate limiting step in the use of glucose. Glimepiride increases very rapidly the number of active glucose transport molecules in the plasma membranes of muscle and fat cells, resulting in stimulated glucose uptake.</p><p>Glimepiride increases the activity of the glycosyl-phosphatidylinositol-specific phospholipase C which may be correlated with the drug-induced lipogenesis and glycogenesis in isolated fat and muscle cells.</p><p>Glimepiride inhibits the glucose production in the liver by increasing the intracellular concentration of fructose-2, 6-bisphosphate, which in its turn inhibits the gluconeogenesis.</p><p><u>General</u></p><p>In healthy persons, the minimum effective oral dose is approximately 0.6 mg. The effect of glimepiride is dose-dependent and reproducible. The physiological response to acute physical exercise, reduction of insulin secretion, is still present under glimepiride.</p><p>There was no significant difference in effect regardless of whether the medicinal product was given 30 minutes or immediately before a meal. In diabetic patients, good metabolic control over 24 hours can be achieved with a single daily dose.</p><p>Although the hydroxy metabolite of glimepiride caused a small but significant decrease in serum glucose in healthy persons, it accounts for only a minor part of the total drug effect.</p><p><u>Combination therapy with metformin</u></p><p>Improved metabolic control for concomitant glimepiride therapy compared to metformin alone in patients not adequately controlled with the maximum dose of metformin has been shown in one study.</p><p><u>Combination therapy with insulin</u></p><p>Data for combination therapy with insulin are limited. In patients not adequately controlled with the maximum dose of glimepiride, concomitant insulin therapy can be initiated. In two studies, the combination achieved the same improvement in metabolic control as insulin alone; however, a lower average dose of insulin was required in combination therapy.</p><p><u>Special populations</u></p><p><em>Paediatric population</em></p><p>An active controlled clinical trial (glimepiride up to 8 mg daily or metformin up to 2,000 mg daily) of 24 weeks duration was performed in 285 children (8-17 years of age) with type 2 diabetes.</p><p>Both glimepiride and metformin exhibited a significant decrease from baseline in HbA<sub>1c </sub>(glimepiride -0.95 (se 0.41); metformin -1.39 (se 0.40)). However, glimepiride did not achieve the criteria of non-inferiority to metformin in mean change from baseline of HbA<sub>1c.</sub> The difference between treatments was 0.44% in favour of metformin. The upper limit (1.05) of the 95% confidence interval for the difference was not below the 0.3% non-inferiority margin.</p><p>Following glimepiride treatment, there were no new safety concerns noted in children compared to adult patients with type 2 diabetes mellitus. No long-term efficacy and safety data are available in paediatric patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption</u></p><p>The bioavailability of glimepiride after oral administration is complete. Food intake has no relevant influence on absorption, only absorption rate is slightly diminished. Maximum serum concentrations (C<sub>max</sub>) are reached approx. 2.5 hours after oral intake (mean 0.3 &micro;g/ml during multiple dosing of 4 mg daily) and there is a linear relationship between dose and both C<sub>max</sub> and AUC (area under the time/concentration curve).</p><p><u>Distribution</u></p><p>Glimepiride has a very low distribution volume (approx. 8.8 litres) which is roughly equal to the albumin distribution space, high protein binding (&gt;99%), and a low clearance (approx. 48 ml/min).</p><p>In animals, glimepiride is excreted in milk. Glimepiride is transferred to the placenta. Passage of the blood brain barrier is low.</p><p><u>Biotransformation and elimination</u></p><p>Mean dominant serum half-life, which is of relevance for the serum concentrations under multiple-dose conditions, is about 5 to 8 hours. After high doses, slightly longer half-lives were noted.</p><p>After a single dose of radiolabelled glimepiride, 58% of the radioactivity was recovered in the urine, and 35% in the faeces. No unchanged substance was detected in the urine. Two metabolites - most probably resulting from hepatic metabolism (major enzyme is CYP2C9) - were identified both in urine and faeces: the hydroxy derivative and the carboxy derivative. After oral administration of glimepiride, the terminal half-lives of these metabolites were 3 to 6 and 5 to 6 hours respectively.</p><p>Comparison of single and multiple once-daily dosing revealed no significant differences in pharmacokinetics, and the intraindividual variability was very low. There was no relevant accumulation.</p><p><u>Special populations</u></p><p>Pharmacokinetics were similar in males and females, as well as in young and elderly (above 65 years) patients. In patients with low creatinine clearance, there was a tendency for glimepiride clearance to increase and for average serum concentrations to decrease, most probably resulting from a more rapid elimination because of lower protein binding. Renal elimination of the two metabolites was impaired. Overall no additional risk of accumulation is to be assumed in such patients.</p><p>Pharmacokinetics in five non-diabetic patients after bile duct surgery were similar to those in healthy persons.</p><p>Paediatric population</p><p>A fed study investigating the pharmacokinetics, safety, and tolerability of a 1 mg single dose of glimepiride in 30 paediatric patients (4 children aged 10-12 years and 26 children aged 12-17 years) with type 2 diabetes showed mean AUC<sub>(0-last)</sub> , Cmax and t<sub>1/2 </sub>similar to that previously observed in adults.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical effects observed occurred at exposures sufficiently in excess of the maximum human exposure as to indicate little relevance to clinical use, or were due to the pharmacodynamic action (hypoglycaemia) of the compound. This finding is based on conventional safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenicity, and reproduction toxicity studies. In the latter (covering embryotoxicity, teratogenicity and developmental toxicity), adverse effects observed were considered to be secondary to the hypoglycaemic effects induced by the compound in dams and in offspring.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Glumine</strong><sup>&reg;</sup> 1</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Name of substances:</p></td></tr><tr><td style="vertical-align:top"><p>Lactose monohydrate</p></td></tr><tr><td style="vertical-align:top"><p>Povidone</p></td></tr><tr><td style="vertical-align:top"><p>Sodium starch Glycolate type A</p></td></tr><tr><td style="vertical-align:top"><p>Cellulose, microcrystalline</p></td></tr><tr><td style="vertical-align:top"><p>Magnesium stearate</p></td></tr><tr><td style="vertical-align:top"><p>Red ferric oxide</p></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p><strong>Glumine</strong><sup>&reg;</sup> 2</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Name of substances</p></td></tr><tr><td style="vertical-align:top"><p>Lactose monohydrate</p></td></tr><tr><td style="vertical-align:top"><p>Povidone</p></td></tr><tr><td style="vertical-align:top"><p>Sodium starch Glycolate type A</p></td></tr><tr><td style="vertical-align:top"><p>Cellulose, microcrystalline</p></td></tr><tr><td style="vertical-align:top"><p>Magnesium stearate</p></td></tr><tr><td style="vertical-align:top"><p>Indigocarmine lake</p></td></tr><tr><td style="vertical-align:top"><p>Yellow ferric oxide</p></td></tr></tbody></table><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p><strong>Glumine<sup>&reg;</sup></strong> 3</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Name of substances</p></td></tr><tr><td style="vertical-align:top"><p>Lactose monohydrate</p></td></tr><tr><td style="vertical-align:top"><p>Povidone</p></td></tr><tr><td style="vertical-align:top"><p>Sodium starch Glycolate type A</p></td></tr><tr><td style="vertical-align:top"><p>Cellulose, microcrystalline</p></td></tr><tr><td style="vertical-align:top"><p>Magnesium stearate</p></td></tr><tr><td style="vertical-align:top"><p>Yellow ferric oxide</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p><strong>Glumine<sup>&reg;</sup></strong> 4</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Name of substances</p></td></tr><tr><td style="vertical-align:top"><p>Lactose monohydrate</p></td></tr><tr><td style="vertical-align:top"><p>Povidone</p></td></tr><tr><td style="vertical-align:top"><p>Sodium starch Glycolate type A</p></td></tr><tr><td style="vertical-align:top"><p>Cellulose, microcrystalline</p></td></tr><tr><td style="vertical-align:top"><p>Magnesium stearate</p></td></tr><tr><td style="vertical-align:top"><p>Indigocarmine lake</p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 months. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Glumine<sup>&reg;</sup> 1&amp; 2 &amp; 3 &amp; 4</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Immediate packaging</p></td><td style="vertical-align:top"><p>Outer Packaging</p></td></tr><tr><td style="vertical-align:top"><p>AL-PVC blister</p></td><td style="vertical-align:top"><p>Cardboard box</p><p>leaflet</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dar Al Dawa Development & Investment Co. Ltd.
P.O.Box 9364 
Na’ur - Jordan  

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                14/10/2014
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>